financetom
Business
financetom
/
Business
/
Pason Systems Renews Normal Course Issuer Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pason Systems Renews Normal Course Issuer Bid
Dec 18, 2024 5:08 AM

07:53 AM EST, 12/18/2024 (MT Newswires) -- Pason Systems ( PSYTF ) overnight Tuesday said the Toronto Stock Exchange approved the extension of it's normal course issuer bid.

The new NCIB will start on Friday and will end on Dec. 19, 2025, or earlier if the bid is completed or terminated by Pason ( PSYTF ). The bid renews the existing NCIB which started on Dec. 20, 2023, and is scheduled to end on Thursday.

Under the 2025 bid, the company said it may buy to cancel up to 7.1 million common shares, or 10% of the public float.

The company also said it intends to enter into an automatic purchase plan with National Bank Financial to buy common shares on Pason's ( PSYTF ) behalf during trading blackout periods, as defined by Pason's ( PSYTF ) insider trading policy.

Shares of the company closed up $0.18 or 1%, to $13.68 on Tuesday on the TSX.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Liberty Global Swings to Q2 Earnings, Revenue Increases
Liberty Global Swings to Q2 Earnings, Revenue Increases
Jul 25, 2024
04:27 PM EDT, 07/25/2024 (MT Newswires) -- Liberty Global ( LBTYA ) reported Q2 earnings late Thursday of $0.71 per diluted share, compared with a loss of $1.13 per share a year earlier. Three analysts polled by Capital IQ expected a loss of $0.73. Revenue for the quarter ended June 30 was $1.87 billion, up from $1.85 billion a year...
Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk Shares Decline Amid Competitive Pressure
Jul 25, 2024
Novo Nordisk A/S Common Stock experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. ( VKTX ) . What To Know: Viking Therapeutics ( VKTX ) announced the company has advanced its obesity candidate VK2735 into late-stage trials. This advancement has intensified competition in the GLP-1 market, which is currently led by...
--PepsiCo Maintains Quarterly Dividend at $1.355 Per Share; Payable Sept. 30 to Shareholders of Record on Sept. 6
--PepsiCo Maintains Quarterly Dividend at $1.355 Per Share; Payable Sept. 30 to Shareholders of Record on Sept. 6
Jul 25, 2024
04:29 PM EDT, 07/25/2024 (MT Newswires) -- Price: 172.00, Change: +0.98, Percent Change: +0.57 ...
VeriSign Q2 Earnings, Revenue Rise; Stock Buyback Boosted by $1.11 Billion
VeriSign Q2 Earnings, Revenue Rise; Stock Buyback Boosted by $1.11 Billion
Jul 25, 2024
04:29 PM EDT, 07/25/2024 (MT Newswires) -- VeriSign ( VRSN ) reported Q2 diluted earnings Thursday of $2.01 per share, up from $1.79 a year earlier. A lone analyst polled by Capital IQ expected $1.94. Revenue in the three months ended June 30 rose to $387.1 million from $372 million a year earlier. Two analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved